Indian APIs (Active Pharmaceuticals Ingredients) Analysis

27
Indian APIs (Active Pharmaceutical Ingredients) Analysis By Sunil Kumar ([email protected])

description

The presentation is analysis of APIs (Active Pharmaceuticals Ingredients) manufactured in India, it can help to choose products for development and setting up marketing strategies for APIs in domestic and overseas market.The analysis has covered detailed analysis of more than 1500 APIs manufactured in India.

Transcript of Indian APIs (Active Pharmaceuticals Ingredients) Analysis

  • 5/21/2018 Indian APIs (Active Pharmaceuticals Ingredients) Analysis

    1/27

    Indian

    APIs (Active Pharmaceutical Ingredients)Analysis

    By Sunil Kumar ([email protected])

  • 5/21/2018 Indian APIs (Active Pharmaceuticals Ingredients) Analysis

    2/27

    WORLD OF APIs

    Globally there are over 7000 APIs are active in 2013

    Altogether APIs creates USD 120 billion world market

    Which is 12% of world pharmaceuticals market

    That is around USD 1000 billion

    World market of APIs is growing at the rate of 8%

    US is biggest market with around 45% share of the world

    market

  • 5/21/2018 Indian APIs (Active Pharmaceuticals Ingredients) Analysis

    3/27

    INDIAN APIs INDUSTRY

    India has around 2300 APIs manufacturing unitsWhich produces around 1500 APIs

    For domestic and International market

    Indian APIs Industry is worth USD 9 billion in 2013Out of which USD 5 billion exported across the world

    Rest USD 4 billion goes for formulation

    Out of which USD 2 billion goes for the formulation for

    exportRest USD 2 billion goes for domestic formulation

    manufacturing

  • 5/21/2018 Indian APIs (Active Pharmaceuticals Ingredients) Analysis

    4/27

    INDIAN APIs INDUSTRY: ASSUMPTIONS

    The basis of the study is export data of APIs andformulations and articles published in different journalsfor the year 2012-13

    The export data suggest USD 5 billion worth APIs goesfor export we assume the domestic consumption (fordomestic and export formulation) is USD 4 billion or80% of the export business

    It must be noted that while USD 2 billion APIs results inUSD 10 billion export of formulation while the samevalue of APIs creates USD 18-20 billion Indian domesticformulation markets

  • 5/21/2018 Indian APIs (Active Pharmaceuticals Ingredients) Analysis

    5/27

    INDIAN APIs INDUSTRY

    Out of 1500 APIs produced in India around 1000 goes

    for export

    Top 50 APIs contributes 50% of the industry

    Top 100 APIs accounts for 70% of the industry

    Top 200 APIs constitutes 85 % of the industry

    Top 500 APIs represents 95% of the industry

  • 5/21/2018 Indian APIs (Active Pharmaceuticals Ingredients) Analysis

    6/27

    The TOP 500 APIs

    Top 500 APIs accounts for 95% of business But the study leaves some APIs which does more than USD

    5 million in export of formulation like ---

    DIDANOSINE, MUPIROCIN, CYCLOSERINE,

    IPRATROPIUM, ZIPRASIDOE, WARFARINSODIUM,GENTAMICIN,BECLOMETHASONE, IRINOTECAN,ZONISAMIDE, MISOPROSTOL, INDAPAMIDE,AMYLMETACRESOL, LEVODOPA, ATRACURIUM,RILUZOLE, PROPOFOL, ISOTRETINOIN,

    OXALIPLATIN, LEVONORGESTREL, ZAFIRLUKAST,ALPRAZOLAM, TROSPIUMCHLORIDE, AZELASTINE,DOXORUBICIN, VECURONIUM, ESTRADIOL,

    NORETHINDRONE, FONDAPARINUX, ETOMIDATE,CEVIMELINE, OCTREOTIDE, ETHINYLESTRADIOL,RITUXIMAB, TIAGABINE, and NORGESTIMATE and

  • 5/21/2018 Indian APIs (Active Pharmaceuticals Ingredients) Analysis

    7/27

    THE MILLION DOLLAR CLUB

    There are 430 APIs whose export is above USD 1 Million

    The club represents 93% of the Industry

    We further filter the list and leave APIs whose average price

    is below USD 25/kg and that leaves few major productswhose export is considerable like----

    NAPROXEN, SALICYLIC ACID, TRICLOSAN, ERYTHROMYCIN,

    RANITIDINE, POVIDONE IODINE, COTRIMOXAZOLE,

    CAFFEINE, DICLOFENAC, METRONIDAZOLE, PERMETHRIN,GUAIFENESIN, SULFAMETHOXAZOLE, NICOTINAMIDE,

    CHLORHEXIDINE, ACETAMINOPHEN, METFORMIN, NIACIN,

    GLYCINE, BENZYL CHLORIDE, CLOXACILLIN, ZINCOXIDE,

    AMPICILLIN, CALCIUM CARBONATE and ALUMINIUM

    HYDROXIDE

  • 5/21/2018 Indian APIs (Active Pharmaceuticals Ingredients) Analysis

    8/27

    THE MILLION DOLLAR CLUB

    Now we are left with 355 APIs for our analysis Which represents around 75% of the industry

    Further we eliminate the APIs whose export is less than

    500 Kg And that leaves some valued products like

    ROCURONIUM, TACROLIMUS, FIDAXOMICIN,ADAPALENE and SIROLIMUS

    Now we are have left with 320 APIs which represents70% of the industry

    AND THAT IS THE BASIS OF INDIAN APIsANALYSIS

  • 5/21/2018 Indian APIs (Active Pharmaceuticals Ingredients) Analysis

    9/27

    THERAUPEUTICAREAS/CATEGOREIS

    ANTI-INFECTIVES

    CARDIOVASCULAR & HEMATOPOIETIC SYSTEM

    CENTRAL NERVOUS SYSTEM

    ENDOCRINE & METABOLIC SYSTEM

    GASTROINTESTINAL & HEPATOBILIARY SYSTEM

    GENITO-URINARY SYSTEM

    MUSCULO-SKELETAL SYSTEM

    ONCOLOGY

    RESPIRATORY SYSTEM OTHERS: DERMATOLOGICALS, ALLERGY & AMMUNE SYSTEM, EAR &

    MOUTH/THROAT, EYE, HORMONES, NUTRITION, VITAMINS &

    MINERALS, ANAESTHETICS -LOCAL & GENERAL,VETERINARYDRUGS

  • 5/21/2018 Indian APIs (Active Pharmaceuticals Ingredients) Analysis

    10/27

    THERAPEUTIC SEGMENTS SHARE

    Therapeutica Areas Industry

    Share in %

    ANTI-INFECTIVES 32.65

    CARDIOVASCULAR & HEMATOPOIETIC SYSTEM 23.48

    CENTRAL NERVOUS SYSTEM 15.89

    RESPIRATORY SYSTEM 8.53

    GASTROINTESTINAL & HEPATOBILIARY SYSTEM 7.84

    MUSCULO-SKELETAL SYSTEM 2.43

    ONCOLOGY 2.14

    GENITO-URINARY SYSTEM 1.8

    ENDOCRINE & METABOLIC SYSTEM 1.65

    OTHERS 3.59

  • 5/21/2018 Indian APIs (Active Pharmaceuticals Ingredients) Analysis

    11/27

    CONTINUE

    ANTI-INFECTIVES

    33%

    CARDIOVASCULAR &

    HEMATOPOIETIC SYSTEM

    23%

    CENTRAL NERVOUS SYSTEM

    16%

    ENDOCRINE &

    METABOLIC

    SYSTEM

    2%

    GASTROINTESTINAL &

    HEPATOBILIARY SYSTEM8%

    GENITO-URINARY SYSTEM

    2%

    MUSCULO-SKELETAL SYSTEM

    2%

    ONCOLOGY

    2%RESPIRATORY SYSTEM

    8%

    OTHERS

    4%

  • 5/21/2018 Indian APIs (Active Pharmaceuticals Ingredients) Analysis

    12/27

    TOP 10 APIs

    Value in USD

    APIsTherapeutic

    AreasExport

    Indian

    MarketTotal

    Lowest

    Price/Kg

    CLOPIDOGREL

    CARDIOVASCULAR & HEMATOPOIETIC

    SYSTEM 113,127,772.16 90,502,217.73 203,629,989.89 61.83

    ATORVASTATIN

    CARDIOVASCULAR & HEMATOPOIETIC

    SYSTEM 96,548,251.42 77,238,601.14 173,786,852.56 253.59

    AMOXYCILLIN ANTI-INFECTIVES (SYSTEMIC) 91,257,244.93 73,005,795.94 164,263,040.87 24.13

    CEFUROXIME ANTI-INFECTIVES (SYSTEMIC) 90,505,803.00 72,404,642.40 162,910,445.40 115.87

    OMEPRAZOLE

    GASTROINTESTINAL & HEPATOBILIARY

    SYSTEM 89,885,147.35 71,908,117.88 161,793,265.23 60.00

    CLARITHROMYCIN ANTI-INFECTIVES (SYSTEMIC) 79,722,899.15 63,778,319.32 143,501,218.47 123.43

    DEXTROMETHORPHAN RESPIRATORY SYSTEM 78,454,335.24 62,763,468.19 141,217,803.43 148.67

    CITALOPRAM CENTRAL NERVOUS SYSTEM 66,944,118.69 53,555,294.95 120,499,413.64 200.07

    VALSARTAN

    CARDIOVASCULAR & HEMATOPOIETIC

    SYSTEM 63,634,936.37 50,907,949.10 114,542,885.47 142.05

    CEFIXIME ANTI-INFECTIVES (SYSTEMIC) 61,014,383.99 48,811,507.19 109,825,891.18 126.53

  • 5/21/2018 Indian APIs (Active Pharmaceuticals Ingredients) Analysis

    13/27

    TOP 10 APIs: ANTI-INFECTIVES

    Value in USD

    APIsSub-Therapeutic

    AreasExport

    Indian

    MarketTotal

    Lowest

    Price/Kg

    AMOXYCILLIN PENICILLINS 91,257,244.93 73,005,795.94 164,263,040.87 24.13

    CEFUROXIME CEPHALOSPORINS 90,505,803.00 72,404,642.40 162,910,445.40 115.87

    CLARITHROMYCIN MACROLIDES 79,722,899.15 63,778,319.32 143,501,218.47 123.43

    CEFIXIME CEPHALOSPORINS 61,014,383.99 48,811,507.19 109,825,891.18 126.53

    CEFACLOR CEPHALOSPORINS 53,948,395.96 43,158,716.77 97,107,112.73 166.12

    TENOFOVIR ANTIVIRALS 53,807,425.50 43,045,940.40 96,853,365.90 332.19

    CIPROFLOXACIN

    EAT ANTI-INFECTIVES & ANTISEPTICS,QUINOLONES, ANTIBACTERIAL

    COMBINATINS, ANTIDIARRHEALS 49,292,536.59 39,434,029.27 88,726,565.86 26.11

    ACYCLOVIR ANTIVIRALS 48,339,569.79 38,671,655.83 87,011,225.62 41.41

    CEFALEXIN CEPHALOSPORINS 37,070,819.21 29,656,655.37 66,727,474.58 44.23

    VALACYCLOVIR ANTIVIRALS 36,327,195.31 29,061,756.25 65,388,951.56 192.21

  • 5/21/2018 Indian APIs (Active Pharmaceuticals Ingredients) Analysis

    14/27

    TOP 10 APIs: CARDIOVASCULAR &

    HEMATOPOIETIC SYSTEM

    Value in USD

    APIsSub-Therapeutic

    AreasExport

    Indian

    MarketTotal

    Lowest

    Price/Kg

    CLOPIDOGREL

    ANTICOAGULANTS, ANTIPLATELETS & FIBRINOLYTICS

    (THROMBOLYTICS) 113,127,772.16 90,502,217.73 203,629,989.89 61.83

    ATORVASTATIN DYSLIPIDAEMIC AGENTS 96,548,251.42 77,238,601.14 173,786,852.56 253.59

    VALSARTAN ANGIOTENSIN II ANTAGONISTS 63,634,936.37 50,907,949.10 114,542,885.47 142.05

    ROSUVASTATIN DYSLIPIDAEMIC AGENTS 56,931,747.75 45,545,398.20 102,477,145.95 949.16

    LOSARTAN ANGIOTENSIN II ANTAGONISTS, 39,860,199.59 31,888,159.67 71,748,359.26 63.23

    IRBESARTAN ANGIOTENSIN II ANTAGONISTS 37,130,963.40 29,704,770.72 66,835,734.12 156.25

    LISINOPRIL ACE INHIBITORS/DIRECT RENIN INHIBITORS 30,279,107.60 24,223,286.08 54,502,393.68 249.48

    AMLODIPINE

    CALCIUM ANTAGONISTS, ANTI-ANGINAL DRUGS, BETA-

    BLOCKERS, CALCIUM ANTAGONISTS, ACE

    INHIBITORS/DIRECT RENIN INHIBITORS 28,318,215.10 22,654,572.08 50,972,787.18 40.18

    SIMVASTATIN DYSLIPIDAEMIC AGENTS 26,653,749.16 21,322,999.33 47,976,748.49 224.32

    HEPARIN

    ANTICOAGULANTS, ANTIPLATELETS & FIBRINOLYTICS

    (THROMBOLYTICS) 23,381,921.67 18,705,537.34 42,087,459.01 1,547.23

  • 5/21/2018 Indian APIs (Active Pharmaceuticals Ingredients) Analysis

    15/27

    TOP 10 APIs: CENTRAL NERVOUS SYSTEM

    Value in USD

    APIsSub-Therapeutic

    AreasExport

    Indian

    MarketTotal

    Lowest

    Price/Kg

    CITALOPRAM ANTIDEPRESSANTS 66,944,118.69 53,555,294.95 120,499,413.64 200.07

    GABAPENTIN

    ANTICONVULSANTS, DRUGS FOR

    NEUROPATHIC PAIN 54,993,418.08 43,994,734.46 98,988,152.54 45.45

    ESCITALOPRAM ANTIDEPRESSANTS 39,828,029.90 31,862,423.92 71,690,453.82 343.52

    LEVETIRACETAM ANTICONVULSANTS 28,187,827.22 22,550,261.78 50,738,089.00 92.71

    PAROXETINE ANTIDEPRESSANTS 27,170,240.25 21,736,192.20 48,906,432.45 405.00

    SERTRALINE ANTIDEPRESSANTS 25,670,868.48 20,536,694.78 46,207,563.26 106.59

    VENLAFAXINE ANXIOLYTICS,ANTIDEPRESSANTS 24,385,914.56 19,508,731.65 43,894,646.21 83.21

    NABUMETONE

    NONSTEROIDAL ANTI-INFLAMMATORY

    DRUGS (NSAIDs) 22,697,951.63 18,158,361.30 40,856,312.93 54.11

    TRAMADOL ANALGESICS (OPIOID) 20,228,926.97 16,183,141.58 36,412,068.55 32.78

    OXCARBAZEPINE ANTICONVULSANTS 18,982,106.90 15,185,685.52 34,167,792.42 99.00

  • 5/21/2018 Indian APIs (Active Pharmaceuticals Ingredients) Analysis

    16/27

    TOP 10 APIs: RESPIRATORY SYSTEM

    Value in USD

    APIsSub-Therapeutic

    AreasExport

    Indian

    MarketTotal

    Lowest

    Price/Kg

    DEXTROMETHORPHAN

    COUGH & COLD

    PREPARATIONS 78,454,335.24 62,763,468.19 141,217,803.43 148.67

    MONTELUKAST

    ANTIASTHMATIC & COPD

    PREPARATIONS 57,727,967.21 46,182,373.77 103,910,340.98 854.27

    LORATADINE

    NASAL DECONGESTANTS &

    OTHER NASAL PREPARATIONS 34,789,681.10 27,831,744.88 62,621,425.98 173.36

    EPHEDRINE ANTI-OBESITY AGENTS 28,241,693.22 22,593,354.58 50,835,047.80 43.17

    PSEUDOEPHEDRINE HCL

    COUGH & COLD

    PREPARATIONS 22,501,033.75 18,000,827.00 40,501,860.75 32.61

    CODEINE

    COUGH & COLD

    PREPARATIONS 21,576,582.54 17,261,266.03 38,837,848.57 25.23

    PHENIRAMINE

    ANTIHISTAMINES &

    ANTIALLERGICS 9,190,574.19 7,352,459.35 16,543,033.54 16.36

    SALBUTAMOL 6,971,400.06 5,577,120.05 12,548,520.11 57.00

    CHLORPHENIRAMINE 6,932,754.38 5,546,203.50 12,478,957.88 16.00

    PHENYLEPHRINE 6,478,375.66 5,182,700.53 11,661,076.19 136.00

  • 5/21/2018 Indian APIs (Active Pharmaceuticals Ingredients) Analysis

    17/27

    TOP 10 APIs: GASTROINTESTINAL &

    HEPATOBILIARY SYSTEM

    Value in USD

    APIsSub-Therapeutic

    AreasExport

    Indian

    MarketTotal

    Lowest

    Price/Kg

    OMEPRAZOLE

    ANTACIDS, ANTIREFLUX

    AGENTS & ANTIULCERANTS 89,885,147.35 71,908,117.88 161,793,265.23 60.00

    PANTOPRAZOLE

    ANTACIDS, ANTIREFLUX

    AGENTS & ANTIULCERANTS 52,392,370.87 41,913,896.70 94,306,267.57 80.80

    ESOMEPRAZOLE

    ANTACIDS, ANTIREFLUX

    AGENTS & ANTIULCERANTS 44,642,855.04 35,714,284.03 80,357,139.07 107.00

    RABEPRAZOLE

    ANTACIDS, ANTIREFLUX

    AGENTS & ANTIULCERANTS 17,775,512.56 14,220,410.05 31,995,922.61 132.32

    LANSOPRAZOLE

    ANTACIDS, ANTIREFLUX

    AGENTS & ANTIULCERANTS 17,028,016.31 13,622,413.05 30,650,429.36 17.15

    RIFAXIMIN ANTIDIARRHEALS 11,994,127.81 9,595,302.25 21,589,430.06 298.18

    HYOSCINE BUTYL BROMIDE ANTISPASMODICS 11,207,584.39 8,966,067.51 20,173,651.90 1,345.12

    FAMOTIDINE 6,990,584.68 5,592,467.74 12,583,052.42 42.00

    URSODIL 4,812,759.21 3,850,207.37 8,662,966.58 353.00

    MEBEVERINE 3,739,520.53 2,991,616.42 6,731,136.95 60.00

  • 5/21/2018 Indian APIs (Active Pharmaceuticals Ingredients) Analysis

    18/27

    TOP 10 APIs: MUSCULO-SKELETAL

    SYSTEM

    Value in USD

    APIsSub-Therapeutic

    AreasExport

    Indian

    MarketTotal

    Lowest

    Price/Kg

    THIOCOLCHICOSIDE MUSCLE RELAXANTS 21,028,203.84 16,822,563.07 37,850,766.91 6,783.67

    ALLOPURINOL

    HYPERURICEMIA & GOUT

    PREPARATIONS 17,897,980.90 14,318,384.72 32,216,365.62 28.80

    CARISOPRODOL MUSCLE RELAXANTS 11,290,349.93 9,032,279.94 20,322,629.87 23.49

    IBANDRONATE 6,311,155.45 5,048,924.36 11,360,079.81 715.00

    PHENYRAMIDOL 5,438,490.36 4,350,792.29 9,789,282.65 93.00

    COLCHICINE 3,677,652.58 2,942,122.06 6,619,774.64 893.00

    ALENDRONATE 3,320,521.22 2,656,416.98 5,976,938.20 38.00

    DIACEREIN 3,201,306.61 2,561,045.29 5,762,351.90 295.00

    CHLORZOXAZONE 2,538,904.74 2,031,123.79 4,570,028.53 14.00

    TIZANIDINE 2,326,605.64 1,861,284.51 4,187,890.15 1,393.00

  • 5/21/2018 Indian APIs (Active Pharmaceuticals Ingredients) Analysis

    19/27

    TOP 5 APIs: ONCOLOGY

    Value in USD

    APIsSub-Therapeutic

    AreasExport

    Indian

    MarketTotal

    Lowest

    Price/Kg

    GEMCITABINE

    CYTOTOXIC

    CHEMOTHERAPY 40,404,865.35 32,323,892.28 72,728,757.63 6,121.79

    IMATINIB

    TARGETED CANCER

    THERAPY 23,389,730.10 18,711,784.08 42,101,514.18 1,455.35

    CAPECITABINE 4,456,115.62 3,564,892.50 8,021,008.12 426.00

    BICALUTAMIDE 4,239,622.78 3,391,698.22 7,631,321.00 738.00

    MELOXICAM 3,306,640.18 2,645,312.14 5,951,952.32 73.00

  • 5/21/2018 Indian APIs (Active Pharmaceuticals Ingredients) Analysis

    20/27

    TOP 10 APIs: GENITO-URINARY SYSTEM

    Value in USD

    APIsSub-Therapeutic

    AreasExport

    Indian

    MarketTotal

    Lowest

    Price/Kg

    MASULOSIN

    DRUGS FOR BLADDER &

    PROSTATE DISORDERS 11,190,244.56 8,952,195.65 20,142,440.21 1,169.32

    TAMSULOSIN

    ACE INHIBITORS/DIRECT RENIN

    INHIBITORS 11,190,244.56 8,952,195.65 20,142,440.21 49.27

    TRIMETHOPRIM URINARY TRACT INFECTIONS 10,594,664.06 8,475,731.25 19,070,395.31 22.65

    SILDENAFIL 8,081,910.88 6,465,528.70 14,547,439.58 36.00

    FINASTERIDE 7,480,116.68 5,984,093.34 13,464,210.02 2,986.00

    PHENAZOPYRIDINE 3,614,695.29 2,891,756.23 6,506,451.52 32.00

    PROBENECID 2,743,350.90 2,194,680.72 4,938,031.62 38.00

    TOLTERODINE 2,643,803.47 2,115,042.78 4,758,846.25 494.00

    CEFDITOREN 2,541,756.59 2,033,405.27 4,575,161.86 1,023.00

    PENICILLAMINE 1,491,748.52 1,193,398.82 2,685,147.34 1,444.00

  • 5/21/2018 Indian APIs (Active Pharmaceuticals Ingredients) Analysis

    21/27

    TOP 10 APIs: ENDOCRINE & METABOLIC

    SYSTEM

    Value in USD

    APIsSub-Therapeutic

    AreasExport

    Indian

    MarketTotal

    Lowest

    Price/Kg

    PIOGLITAZONE ANTIDIABETIC AGENTS 14,538,744.26 11,630,995.41 26,169,739.67 95.03

    ORLISTAT ANTI-OBESITY AGENTS 11,925,939.75 9,540,751.80 21,466,691.55 740.00

    GLIMEPIRIDE 6,605,904.37 5,284,723.50 11,890,627.87 335.00

    GLICLAZIDE 4,369,257.44 3,495,405.95 7,864,663.39 131.00

    REPAGLINIDE 4,009,591.01 3,207,672.81 7,217,263.82 2,728.00

    NATEGLINIDE 3,828,042.01 3,062,433.61 6,890,475.62 435.00

    GLIPIZIDE 3,200,115.21 2,560,092.17 5,760,207.38 187.00

    SITAGLIPTIN 3,109,199.99 2,487,359.99 5,596,559.98 766.00

    GLYBURIDE OR

    GLIBENCLAMIDE 3,103,533.66 2,482,826.93 5,586,360.59 31.00

    RISEDRONATE SODIUM 1,979,262.61 1,583,410.09 3,562,672.70 643.00

  • 5/21/2018 Indian APIs (Active Pharmaceuticals Ingredients) Analysis

    22/27

    TOP 10 APIs: OTHERS

    Value in USD

    APIsSub-Therapeutic

    AreasExport

    Indian

    MarketTotal

    Lowest

    Price/Kg

    TRICLABENDAZOLE VETERINARY DRUGS 10,569,294.98 8,455,435.98 19,024,730.96 59.98

    DESLORATADINE ALLERGY & AMMUNE SYSTEM 8,374,530.38 6,699,624.30 15,074,154.68 311.56

    BENZETHONIUM CHLORIDE DERMATOLOGICALS 8,174,060.42 6,539,248.34 14,713,308.76 30.00

    DORZOLAMIDE EYE 7,612,650.70 6,090,120.56 13,702,771.26 3,974.00

    HYDROCORTISONE HORMONES 6,676,926.25 5,341,541.00 12,018,467.25 820.00

    RACTOPAMINE VETERINARY DRUGS 6,561,142.75 5,248,914.20 11,810,056.95 322.00

    CLOBETASOL EYE 6,419,728.18 5,135,782.54 11,555,510.72 1,927.00

    BETAMETHASONE EAR & MOUTH/THROAT 6,081,371.83 4,865,097.46 10,946,469.29 1,668.00

    HYDROCORTISONE SODIUM

    SUCCINATE HORMONES 6,064,140.25 4,851,312.20 10,915,452.45 854.00

    ARTICAINE

    ANAESTHETICS - LOCAL &

    GENERAL 5,906,888.76 4,725,511.01 10,632,399.77 182.00

  • 5/21/2018 Indian APIs (Active Pharmaceuticals Ingredients) Analysis

    23/27

    TOP 10 APIs: EXPORT> USD5 Mn,

    VLUE: USD 500 -1000/Kg

    Value in USD

    APIsSub-Therapeutic

    AreasExport

    Indian

    MarketTotal

    Lowest

    Price/Kg

    MONTELUKAST RESPIRATORY SYSTEM 57,727,967.21 46,182,373.77 103,910,340.98 854.27

    ROSUVASTATIN

    CARDIOVASCULAR &

    HEMATOPOIETIC SYSTEM 56,931,747.75 45,545,398.20 102,477,145.95 949.16

    SUMATRIPTAN CENTRAL NERVOUS SYSTEM 15,899,307.92 12,719,446.34 28,618,754.26 779.37

    FLUVASTATIN

    CARDIOVASCULAR &

    HEMATOPOIETIC SYSTEM 13,547,955.56 10,838,364.45 24,386,320.01 741.84

    ORLISTAT

    ENDOCRINE & METABOLIC

    SYSTEM 11,925,939.75 9,540,751.80 21,466,691.55 740.00

    LERCANIDIPINE CARDIOVASCULAR &HEMATOPOIETIC SYSTEM 11,387,619.57 9,110,095.66 20,497,715.23 952.57

    LOPINAVIR ANTI-INFECTIVES (SYSTEMIC) 7,002,709.04 5,602,167.23 12,604,876.27 696.00

    HYDROCORTISONE HORMONES 6,676,926.25 5,341,541.00 12,018,467.25 820.00

    IBANDRONATE MUSCULO-SKELETAL SYSTEM 6,311,155.45 5,048,924.36 11,360,079.81 715.00

    HYDROCORTISONE SODIUM

    SUCCINATE HORMONES 6,064,140.25 4,851,312.20 10,915,452.45 854.00

  • 5/21/2018 Indian APIs (Active Pharmaceuticals Ingredients) Analysis

    24/27

    TOP 10 APIs: Export > USD 5 Mn,

    VALUE: USD100-500/Kg

    Value in USD

    APIsSub-Therapeutic

    AreasExport

    Indian

    MarketTotal

    Lowest

    Price/Kg

    ATORVASTATIN

    CARDIOVASCULAR &

    HEMATOPOIETIC SYSTEM 96,548,251.42 77,238,601.14 173,786,852.56 253.59

    TENOFOVIR ANTI-INFECTIVES (SYSTEMIC) 53,807,425.50 43,045,940.40 96,853,365.90 332.19

    ESCITALOPRAM CENTRAL NERVOUS SYSTEM 39,828,029.90 31,862,423.92 71,690,453.82 343.52

    LISINOPRIL

    CARDIOVASCULAR &

    HEMATOPOIETIC SYSTEM 30,279,107.60 24,223,286.08 54,502,393.68 249.48

    PAROXETINE CENTRAL NERVOUS SYSTEM 27,170,240.25 21,736,192.20 48,906,432.45 405.00

    CEFDINIR ANTI-INFECTIVES (SYSTEMIC) 23,664,993.08 18,931,994.46 42,596,987.54 286.87

    RAMIPRIL

    CARDIOVASCULAR &

    HEMATOPOIETIC SYSTEM 16,801,622.49 13,441,297.99 30,242,920.48 327.94

    CEFPROZIL ANTI-INFECTIVES (SYSTEMIC) 14,618,836.07 11,695,068.86 26,313,904.93 401.82

    RIFAXIMIN

    GASTROINTESTINAL &

    HEPATOBILIARY SYSTEM 11,994,127.81 9,595,302.25 21,589,430.06 298.18

    ARTEMETHER ANTI-INFECTIVES (SYSTEMIC) 11,382,428.56 9,105,942.85 20,488,371.41 495.00

  • 5/21/2018 Indian APIs (Active Pharmaceuticals Ingredients) Analysis

    25/27

    TOP 10 APIs: BY VOLUME

    Value in USD

    APIsTherapeutic

    AreasExport

    Indian

    MarketTotal

    Lowest

    Price/Kg

    Export

    in MTS

    AMOXYCILLIN

    ANTI-INFECTIVES

    (SYSTEMIC) 91,257,244.93 73,005,795.94 164,263,040.87 24.13 3,140.774

    OMEPRAZOLE

    GASTROINTESTINAL &

    HEPATOBILIARY

    SYSTEM 89,885,147.35 71,908,117.88 161,793,265.23 60.00 2,673.176

    CIPROFLOXACINANTI-INFECTIVES(SYSTEMIC) 49,292,536.59 39,434,029.27 88,726,565.86 26.11 1,434.307

    GABAPENTIN

    CENTRAL NERVOUS

    SYSTEM 54,993,418.08 43,994,734.46 98,988,152.54 45.45 1,023.985

    AMLODIPINE

    CARDIOVASCULAR &

    HEMATOPOIETIC

    SYSTEM 28,318,215.10 22,654,572.08 50,972,787.18 40.18 763.721

    CEFALEXIN

    ANTI-INFECTIVES

    (SYSTEMIC) 37,070,819.21 29,656,655.37 66,727,474.58 44.23 749.841

    CODEINE RESPIRATORY SYSTEM 21,576,582.54 17,261,266.03 38,837,848.57 25.23 611.706

    ATENOLOL

    CARDIOVASCULAR &

    HEMATOPOIETIC

    SYSTEM 15,481,607.22 12,385,285.78 27,866,893.00 17.92 587.789

    TRAMADOL

    CENTRAL NERVOUS

    SYSTEM 20,228,926.97 16,183,141.58 36,412,068.55 32.78 524.087

    CEFUROXIME

    ANTI-INFECTIVES

    (SYSTEMIC) 90,505,803.00 72,404,642.40 162,910,445.40 115.87 513.861

  • 5/21/2018 Indian APIs (Active Pharmaceuticals Ingredients) Analysis

    26/27

    TOP 10 APIs: BY VALUE

    Value in USD

    APIsTherapeutic

    AreasExport

    Indian

    MarketTotal

    Lowest

    Price/Kg

    CILAZAPRIL

    CARDIOVASCULAR &

    HEMATOPOIETIC SYSTEM 7,103,329.50 5,682,663.60 12,785,993.10 6,983.00

    THIOCOLCHICOSIDE MUSCULO-SKELETAL SYSTEM 21,028,203.84 16,822,563.07 37,850,766.91 6,783.67

    GEMCITABINE ONCOLOGY 40,404,865.35 32,323,892.28 72,728,757.63 6,121.79

    VORICONAZOLE ANTI-INFECTIVES (SYSTEMIC) 6,869,564.74 5,495,651.79 12,365,216.53 4,393.00

    DORZOLAMIDE EYE 7,612,650.70 6,090,120.56 13,702,771.26 3,974.00

    DARUNAVIR ANTI-INFECTIVES (SYSTEMIC) 3,471,649.79 2,777,319.83 6,248,969.62 3,892.00

    VALGANCICLOVIR ANTI-INFECTIVES (SYSTEMIC) 1,154,667.73 923,734.18 2,078,401.91 3,707.00

    NEBIVOLOL

    CARDIOVASCULAR &

    HEMATOPOIETIC SYSTEM 22,545,134.58 18,036,107.66 40,581,242.24 3,686.07

    RIVASTIGMINE CENTRAL NERVOUS SYSTEM 7,524,671.06 6,019,736.85 13,544,407.91 3,369.00

    FINASTERIDE GENITO-URINARY SYSTEM 7,480,116.68 5,984,093.34 13,464,210.02 2,986.00

  • 5/21/2018 Indian APIs (Active Pharmaceuticals Ingredients) Analysis

    27/27

    Thank [email protected]

    mailto:[email protected]:[email protected]